ID

18515

Description

Non-small Cell Lung Cancer Registry; ODM derived from: https://clinicaltrials.gov/show/NCT00099541

Link

https://clinicaltrials.gov/show/NCT00099541

Keywords

Versions (1)
  1. 11/9/16 11/9/16 -
Uploaded on

November 9, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Non-Small-Cell Lung Cancer NCT00099541

English

Eligibility Non-Small-Cell Lung Cancer NCT00099541

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age greater than or equal to 18 years
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
histologically confirmed nsclc (squamous cell carcinoma, adenocarcinoma, large cell carcinoma).
Description

Non-Small Cell Lung Carcinoma | Squamous cell carcinoma | Adenocarcinoma | Carcinoma, Large Cell

Data type

boolean

Alias
UMLS CUI [1]
C0007131
UMLS CUI [2]
C0007137
UMLS CUI [3]
C0001418
UMLS CUI [4]
C0206704
unresectable stage iiib with pleural effusion or stage iv nsclc
Description

Non-Small Cell Lung Carcinoma unresectable | TNM clinical staging | Pleural effusion

Data type

boolean

Alias
UMLS CUI [1,1]
C0007131
UMLS CUI [1,2]
C1519810
UMLS CUI [2]
C3258246
UMLS CUI [3]
C0032227
ecog performance status of 0 or 1
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients who received an iv bisphosphonate (e.g.pamidronate; zoledronic acid)
Description

Intravenous bisphosphonates | pamidronate | zoledronic acid

Data type

boolean

Alias
UMLS CUI [1]
C1955566
UMLS CUI [2]
C0043603
UMLS CUI [3]
C0257685
patients who received an oral bisphosphonate therapy in the 6 months prior to screening (alendronate; etidronate; risedronate; tiludronate; ibandronate)
Description

Diphosphonates Oral | Alendronate | Etidronate | Risedronate | Tiludronate | Ibandronate

Data type

boolean

Alias
UMLS CUI [1,1]
C0012544
UMLS CUI [1,2]
C1527415
UMLS CUI [2]
C0102118
UMLS CUI [3]
C0086268
UMLS CUI [4]
C0246719
UMLS CUI [5]
C0145942
UMLS CUI [6]
C0379199
patients who are currently receiving any investigational drugs that are suspected to have renal toxicity and/or are excreted by the kidneys
Description

Investigational New Drugs Associated with Toxic nephropathy | Investigational New Drugs Related Kidney Excretion

Data type

boolean

Alias
UMLS CUI [1,1]
C0013230
UMLS CUI [1,2]
C0332281
UMLS CUI [1,3]
C0595916
UMLS CUI [2,1]
C0013230
UMLS CUI [2,2]
C0439849
UMLS CUI [2,3]
C0022646
UMLS CUI [2,4]
C0221102
known clinically significant hypersensitivity to zoledronic acid or other bisphosphonates or any of the excipients in the formulation of zoledronic acid (mannitol, sodium citrate)
Description

Hypersensitivity Clinical Significance zoledronic acid | Hypersensitivity Clinical Significance Diphosphonates | Hypersensitivity Clinical Significance zoledronic acid Excipient | Hypersensitivity Clinical Significance Mannitol | Hypersensitivity Clinical Significance sodium citrate

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C2826293
UMLS CUI [1,3]
C0257685
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C2826293
UMLS CUI [2,3]
C0012544
UMLS CUI [3,1]
C0020517
UMLS CUI [3,2]
C2826293
UMLS CUI [3,3]
C0257685
UMLS CUI [3,4]
C0015237
UMLS CUI [4,1]
C0020517
UMLS CUI [4,2]
C2826293
UMLS CUI [4,3]
C0024730
UMLS CUI [5,1]
C0020517
UMLS CUI [5,2]
C2826293
UMLS CUI [5,3]
C0142825
abnormal renal function or creatinine clearance
Description

Abnormal renal function | Creatinine clearance Abnormal

Data type

boolean

Alias
UMLS CUI [1]
C0151746
UMLS CUI [2,1]
C0812399
UMLS CUI [2,2]
C0205161
unstable brain metastasis
Description

Metastatic malignant neoplasm to brain Unstable

Data type

boolean

Alias
UMLS CUI [1,1]
C0220650
UMLS CUI [1,2]
C0443343
women of childbearing potential not using a medically recognized form of contraception, as well as women who are breastfeeding
Description

Childbearing Potential Contraceptive methods Inadequate | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
UMLS CUI [1,3]
C0205412
UMLS CUI [2]
C0006147
patients with nonmalignant conditions which would confound the evaluation of the primary endpoint, impair tolerance of therapy, or prevent compliance to the protocol
Description

Condition Non-Malignant Affecting Evaluation Primary Endpoint | Condition Non-Malignant Affecting Therapeutic procedure | Condition Non-Malignant Preventing Protocol Compliance

Data type

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C1518371
UMLS CUI [1,3]
C0392760
UMLS CUI [1,4]
C1261322
UMLS CUI [1,5]
C2986535
UMLS CUI [2,1]
C0348080
UMLS CUI [2,2]
C1518371
UMLS CUI [2,3]
C0392760
UMLS CUI [2,4]
C0087111
UMLS CUI [3,1]
C0348080
UMLS CUI [3,2]
C1518371
UMLS CUI [3,3]
C1292733
UMLS CUI [3,4]
C0525058
Back to the top of the page

Similar models

Eligibility Non-Small-Cell Lung Cancer NCT00099541

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age greater than or equal to 18 years
boolean
C0001779 (UMLS CUI [1])
Non-Small Cell Lung Carcinoma | Squamous cell carcinoma | Adenocarcinoma | Carcinoma, Large Cell
Item
histologically confirmed nsclc (squamous cell carcinoma, adenocarcinoma, large cell carcinoma).
boolean
C0007131 (UMLS CUI [1])
C0007137 (UMLS CUI [2])
C0001418 (UMLS CUI [3])
C0206704 (UMLS CUI [4])
Non-Small Cell Lung Carcinoma unresectable | TNM clinical staging | Pleural effusion
Item
unresectable stage iiib with pleural effusion or stage iv nsclc
boolean
C0007131 (UMLS CUI [1,1])
C1519810 (UMLS CUI [1,2])
C3258246 (UMLS CUI [2])
C0032227 (UMLS CUI [3])
ECOG performance status
Item
ecog performance status of 0 or 1
boolean
C1520224 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Intravenous bisphosphonates | pamidronate | zoledronic acid
Item
patients who received an iv bisphosphonate (e.g.pamidronate; zoledronic acid)
boolean
C1955566 (UMLS CUI [1])
C0043603 (UMLS CUI [2])
C0257685 (UMLS CUI [3])
Diphosphonates Oral | Alendronate | Etidronate | Risedronate | Tiludronate | Ibandronate
Item
patients who received an oral bisphosphonate therapy in the 6 months prior to screening (alendronate; etidronate; risedronate; tiludronate; ibandronate)
boolean
C0012544 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0102118 (UMLS CUI [2])
C0086268 (UMLS CUI [3])
C0246719 (UMLS CUI [4])
C0145942 (UMLS CUI [5])
C0379199 (UMLS CUI [6])
Investigational New Drugs Associated with Toxic nephropathy | Investigational New Drugs Related Kidney Excretion
Item
patients who are currently receiving any investigational drugs that are suspected to have renal toxicity and/or are excreted by the kidneys
boolean
C0013230 (UMLS CUI [1,1])
C0332281 (UMLS CUI [1,2])
C0595916 (UMLS CUI [1,3])
C0013230 (UMLS CUI [2,1])
C0439849 (UMLS CUI [2,2])
C0022646 (UMLS CUI [2,3])
C0221102 (UMLS CUI [2,4])
Hypersensitivity Clinical Significance zoledronic acid | Hypersensitivity Clinical Significance Diphosphonates | Hypersensitivity Clinical Significance zoledronic acid Excipient | Hypersensitivity Clinical Significance Mannitol | Hypersensitivity Clinical Significance sodium citrate
Item
known clinically significant hypersensitivity to zoledronic acid or other bisphosphonates or any of the excipients in the formulation of zoledronic acid (mannitol, sodium citrate)
boolean
C0020517 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
C0257685 (UMLS CUI [1,3])
C0020517 (UMLS CUI [2,1])
C2826293 (UMLS CUI [2,2])
C0012544 (UMLS CUI [2,3])
C0020517 (UMLS CUI [3,1])
C2826293 (UMLS CUI [3,2])
C0257685 (UMLS CUI [3,3])
C0015237 (UMLS CUI [3,4])
C0020517 (UMLS CUI [4,1])
C2826293 (UMLS CUI [4,2])
C0024730 (UMLS CUI [4,3])
C0020517 (UMLS CUI [5,1])
C2826293 (UMLS CUI [5,2])
C0142825 (UMLS CUI [5,3])
Abnormal renal function | Creatinine clearance Abnormal
Item
abnormal renal function or creatinine clearance
boolean
C0151746 (UMLS CUI [1])
C0812399 (UMLS CUI [2,1])
C0205161 (UMLS CUI [2,2])
Metastatic malignant neoplasm to brain Unstable
Item
unstable brain metastasis
boolean
C0220650 (UMLS CUI [1,1])
C0443343 (UMLS CUI [1,2])
Childbearing Potential Contraceptive methods Inadequate | Breast Feeding
Item
women of childbearing potential not using a medically recognized form of contraception, as well as women who are breastfeeding
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0205412 (UMLS CUI [1,3])
C0006147 (UMLS CUI [2])
Condition Non-Malignant Affecting Evaluation Primary Endpoint | Condition Non-Malignant Affecting Therapeutic procedure | Condition Non-Malignant Preventing Protocol Compliance
Item
patients with nonmalignant conditions which would confound the evaluation of the primary endpoint, impair tolerance of therapy, or prevent compliance to the protocol
boolean
C0348080 (UMLS CUI [1,1])
C1518371 (UMLS CUI [1,2])
C0392760 (UMLS CUI [1,3])
C1261322 (UMLS CUI [1,4])
C2986535 (UMLS CUI [1,5])
C0348080 (UMLS CUI [2,1])
C1518371 (UMLS CUI [2,2])
C0392760 (UMLS CUI [2,3])
C0087111 (UMLS CUI [2,4])
C0348080 (UMLS CUI [3,1])
C1518371 (UMLS CUI [3,2])
C1292733 (UMLS CUI [3,3])
C0525058 (UMLS CUI [3,4])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial